Skip to main content
Veterinary Medicines

Virbagen canis SHAPPi/LT, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde

Authorised
  • Canine distemper virus, strain Lederle VR128, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
  • Rabies virus, strain VP12, Inactivated

Product identification

Medicine name:
Virbagen canis SHAPPi/LT, Lyophilisat und Suspension zur Herstellung einer Injektionssuspension für Hunde
Active substance:
  • Canine distemper virus, strain Lederle VR128, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
  • Rabies virus, strain VP12, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle VR128, Live
    5.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    6.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain Cornell 780916, Live
    7.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain Manhattan, Live
    7.00
    log10 tissue culture infective dose 50
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain Virbac CBS, Inactivated
    833.00
    million organisms
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain Virbac IS3, Inactivated
    833.00
    million organisms
    /
    1.00
    millilitre(s)
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-20138
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 12/06/2024
Updated on: 3/12/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."